|
AKAP11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.21249999995854E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.23659999999804E-05 |
| Normal-vs-Stage2 |
7.354600E-04 |
| Normal-vs-Stage3 |
5.60890000000924E-07 |
| Normal-vs-Stage4 |
2.26930000002401E-06 |
| Stage1-vs-Stage2 |
5.898800E-01 |
| Stage1-vs-Stage3 |
1.243210E-01 |
| Stage1-vs-Stage4 |
9.444200E-02 |
| Stage2-vs-Stage3 |
5.940600E-01 |
| Stage2-vs-Stage4 |
5.056000E-01 |
| Stage3-vs-Stage4 |
8.065800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26899999997043E-06 |
| Normal-vs-AfricanAmerican |
1.098040E-01 |
| Normal-vs-Asian |
2.786500E-04 |
| Caucasian-vs-AfricanAmerican |
1.330010E-01 |
| Caucasian-vs-Asian |
9.114000E-01 |
| AfricanAmerican-vs-Asian |
1.941550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.79520000479039E-08 |
| Normal-vs-Female |
3.86230000000154E-05 |
| Male-vs-Female |
3.849800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.163700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.24249999994475E-06 |
| Normal-vs-Age(61-80Yrs) |
2.3894999999774E-06 |
| Normal-vs-Age(81-100Yrs) |
4.779900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.956150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.803600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.081800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.642200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.980200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.249000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.240040E-01 |
| Classical-VS-Follicular |
4.723700E-02 |
| Classical-VS-Other |
1.523810E-01 |
| Classical-VS-Normal |
1.020330E-04 |
| Tall-VS-Follicular |
9.303800E-01 |
| Tall-VS-Other |
3.553800E-01 |
| Tall-VS-Normal |
1.770190E-04 |
| Follicular-VS-Other |
5.004200E-01 |
| Follicular-VS-Normal |
1.75597999999555E-05 |
| Other-VS-Normal |
4.982900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.87059999998429E-07 |
| Normal-vs-N1 |
1.74832999999541E-05 |
| N0-vs-N1 |
7.542000E-01 |
|
|
